These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 24261762

  • 1. Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus.
    Shimada Y, Asanuma YF, Yokota K, Yoshida Y, Kajiyama H, Sato K, Akiyama Y, Mimura T.
    Mod Rheumatol; 2014 Jan; 24(1):78-85. PubMed ID: 24261762
    [Abstract] [Full Text] [Related]

  • 2. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P, Hrycek A.
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [Abstract] [Full Text] [Related]

  • 3. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
    Sahin S, Adrovic A, Barut K, Durmus S, Gelisgen R, Uzun H, Kasapcopur O.
    Lupus; 2017 Sep; 26(10):1089-1094. PubMed ID: 28420068
    [Abstract] [Full Text] [Related]

  • 4. Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus.
    Jung JY, Koh BR, Bae CB, Kim HA, Suh CH.
    Lupus; 2014 Dec; 23(14):1517-22. PubMed ID: 25059488
    [Abstract] [Full Text] [Related]

  • 5. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L, Enocsson H, Skogh T, Eloranta ML, Rönnblom L, Sjöwall C, Wetterö J.
    Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
    [Abstract] [Full Text] [Related]

  • 6. Plasma pentraxin 3 levels are associated with carotid IMT in type 1 diabetic patients.
    Katakami N, Kaneto H, Sakamoto F, Takahara M, Irie Y, Fujisawa K, Miyashita K, Yasuda T, Matsuoka TA, Yoshiuchi K, Sakamoto K, Kuroda A, Matsuhisa M, Kosugi K, Shimomura I.
    Diabetes Res Clin Pract; 2013 Feb; 99(2):185-91. PubMed ID: 23245734
    [Abstract] [Full Text] [Related]

  • 7. Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study.
    Asanuma YF, Aizaki Y, Noma H, Yokota K, Matsuda M, Kozu N, Takebayashi Y, Nakatani H, Hasunuma T, Kawai S, Mimura T.
    Mod Rheumatol; 2020 Nov; 30(6):959-966. PubMed ID: 31615315
    [Abstract] [Full Text] [Related]

  • 8. Circulating pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis.
    Wu Q, Guan SY, Dan YL, Zhao CN, Mao YM, Liu LN, Li XM, Wang DG, Pan HF.
    Biomark Med; 2019 Nov; 13(16):1417-1427. PubMed ID: 31599644
    [Abstract] [Full Text] [Related]

  • 9. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
    Maksimowicz-McKinnon K, Magder LS, Petri M.
    J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD.
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [Abstract] [Full Text] [Related]

  • 11. Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with cyclosporine A.
    Oryoji K, Kiyohara C, Horiuchi T, Tsukamoto H, Niiro H, Shimoda T, Akashi K, Yanase T.
    Mod Rheumatol; 2014 Jan; 24(1):86-92. PubMed ID: 24261763
    [Abstract] [Full Text] [Related]

  • 12. Serum Levels of Pentraxin3 and Interlukin36 in Patients with Systemic Lupus and their Relation to Disease Activity.
    Ismail SM, Abd-ELWahab MK, Mohamed MS.
    Egypt J Immunol; 2018 Jan; 25(1):81-91. PubMed ID: 30243000
    [Abstract] [Full Text] [Related]

  • 13. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus.
    Bassi N, Ghirardello A, Blank M, Zampieri S, Sarzi-Puttini P, Mantovani A, Shoenfeld Y, Doria A.
    Ann Rheum Dis; 2010 Sep; 69(9):1704-10. PubMed ID: 20439287
    [Abstract] [Full Text] [Related]

  • 14. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
    Hollan I, Bottazzi B, Cuccovillo I, Førre ØT, Mikkelsen K, Saatvedt K, Almdahl SM, Mantovani A, Meroni PL, Feiring Heart Biopsy Study Group.
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):378-85. PubMed ID: 20391484
    [Abstract] [Full Text] [Related]

  • 15. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
    Yuan M, Tan Y, Pang Y, Li YZ, Song Y, Yu F, Zhao MH.
    Ren Fail; 2017 Nov; 39(1):465-473. PubMed ID: 28393653
    [Abstract] [Full Text] [Related]

  • 16. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.
    Roman MJ, Crow MK, Lockshin MD, Devereux RB, Paget SA, Sammaritano L, Levine DM, Davis A, Salmon JE.
    Arthritis Rheum; 2007 Oct; 56(10):3412-9. PubMed ID: 17907140
    [Abstract] [Full Text] [Related]

  • 17. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mok CC, Poon WL, Lai JP, Wong CK, Chiu SM, Wong CK, Lun SW, Ko GT, Lam CW, Lam CS.
    Scand J Rheumatol; 2010 Oct; 39(1):42-9. PubMed ID: 20132070
    [Abstract] [Full Text] [Related]

  • 18. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
    Fischer K.
    Ann Acad Med Stetin; 2008 Oct; 54(2):22-32. PubMed ID: 19374227
    [Abstract] [Full Text] [Related]

  • 19. [Soluble CD40 ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection].
    Popkova TV, Panafidina TA, Aleksandrova EN, Novikova DS, Novikov AA, Alekberova ZS, Mach ES, Nasonov EL.
    Ter Arkh; 2008 Oct; 80(5):37-41. PubMed ID: 18590112
    [Abstract] [Full Text] [Related]

  • 20. Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus.
    Kay SD, Poulsen MK, Diederichsen AC, Voss A.
    J Rheumatol; 2016 Feb; 43(2):315-22. PubMed ID: 26628595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.